Morgan Stanley Call 260 AMG 20.09.../ DE000MB0CPR0 /

2/3/2023 9:56:38 PM	Chg.+0.07	Bid10:00:25 PM	Ask10:00:25 PM	Underlying	Strike price	Expiration date	Option type
2.40EUR	+3.00%	- Bid Size: -	- Ask Size: -	AMGEN INC. DL-...	260.00 -	9/20/2024	Call

TeleTrader 2/1 Dow dips 200 pts at open as markets brace for Fed guidance

TeleTrader 1/31 Amgen: Net income down 15% in Q4 to $1.6 billion

TeleTrader 1/31 Dow up by 200 pts ahead of interest rate decision

TeleTrader 12/12/2022 US stocks end strong day, Dow up over 500 pts

TeleTrader 12/12/2022 US kicks off with gains as markets brace for rate hikes

TeleTrader 12/12/2022 Amgen to buy Horizon for $26.4 billion

TeleTrader 12/11/2022 Amgen close to buying Horizon, worth over $20B - report

TeleTrader 11/8/2022 US stocks close higher amid midterm elections

TeleTrader 11/8/2022 US stocks rally as markets brace for midterm elections

TeleTrader 11/4/2022 US opens higher after nonfarm payrolls report

TeleTrader 11/3/2022 Amgen sees EPS soaring 20% to $3.98 in Q3

TeleTrader 11/3/2022 US closes lower ahead of another batch of earnings

TeleTrader 11/3/2022 Wall Street opens lower after Fed hikes rate again

TeleTrader 10/24/2022 US closes higher with major earnings reports in focus

TeleTrader 10/24/2022 Wall Street extends gains, Dow soars 500 points

TeleTrader 10/24/2022 US markets open mostly higher amid earnings releases

TeleTrader 10/19/2022 Dow falls 250 pts as Wall Street changes course again

TeleTrader 10/11/2022 Wall Street closes mostly lower after BoE warning

TeleTrader 8/31/2022 US opens higher with economy in focus

TeleTrader 8/4/2022 Amgen's Q2 EPS triples to $2.45

TeleTrader 8/4/2022 US closes mostly lower after labor market data

TeleTrader 8/4/2022 US opens mostly flat after trade, jobs data

TeleTrader 6/2/2022 Wall Street opens lower amid data

GlobeNewswire 3/23/2022 CytomX Therapeutics Announces Retirement of Frederick W. Gluck from Board of Directors

GlobeNewswire 3/23/2022 OcyonBio Client Biosimilar Solutions, Inc. Initiates Registrational Clinical Trial for Its First Bio...